SLDB
Solid Biosciences LLC
NASDAQ: SLDB · HEALTHCARE · BIOTECHNOLOGY
$7.26
+2.98% today
Updated 2026-04-30
Market cap
$733.18M
P/E ratio
—
P/S ratio
3.65x
EPS (TTM)
$-1.99
Dividend yield
—
52W range
$2 – $9
Volume
1.3M
Solid Biosciences LLC (SLDB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-109.90%
ROA
-53.20%
Debt/equity
0.10x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-6.38M | — | — | — |
| 2016 | $0.00 | $-21.54M | — | — | — |
| 2017 | $0.00 | $-52.12M | — | — | — |
| 2018 | $0.00 | $-74.80M | — | — | — |
| 2019 | $0.00 | $-117.22M | — | — | — |
| 2020 | $3.33M | $-88.29M | -117.60% | -2,592.56% | -2,647.38% |
| 2021 | $13.62M | $-72.19M | 100.00% | -530.50% | -530.01% |
| 2022 | $8.09M | $-85.98M | 100.00% | -1,315.20% | -1,062.28% |
| 2023 | $0.00 | $-96.02M | — | — | — |
| 2024 | $0.00 | $-124.70M | — | — | — |
| 2025 | $0.00 | $-174.32M | — | — | — |